Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen to Acquire DNA Research Innovations for $30 Million Cash, Other Payments

NEW YORK , Oct. 28 (GenomeWeb News) - Invitrogen will acquire DNA Research Innovations of Kent, UK, for $30 million in cash and $30 million in payments contingent on the completion of research and development milestones, the company said today.


Privately held DNA Research Innovation develops and sells ChargeSwitch technology, a DNA/RNA purification technology.


The acquisition follows Invitrogen's purchase of Protometrix in April; Xeotron in May; and Molecular Probes in August.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.